Mirko Stange

Macula is transforming clinical microscopy workflow by deploying a compact and rapid computational imaging platform to enable true hands-off automation. Your whole slide is scanned and interpreted on-board leveraging latest AI/ML architectures in minutes. Report and high-fidelity images are available on the system for local or remote review.

OMAPiX, Inc., a dynamic solutions-driven CRO based in Frederick, MD, delivers concierge multiomics services tailored to tackle a wide range of scientific challenges. Our technology-agnostic lab, combined with cutting-edge custom analysis methods, provides seamless end-to-end solutions across genomics, transcriptomics, and proteomics. Backed by extensive hands-on expertise in both wet lab and analytical techniques, OMAPiX is a trusted partner for academia, biotech, and pharma, supporting every stage of research with confidence and precision.

75% of lung cancer cases are detected too late. OncoSwab is changing that. Our mission: make early detection accessible with a non-invasive, easy-to-use test. Founded by visionary scientists and supported by the Health Wildcatters Accelerator, Swiss Governments DayOne Tech, and several pre-seed investors, OncoSwab is currently conducting a proof-of-concept trial with the collaboration of top US and European hospitals and lung cancer experts, aiming to save lives worldwide. OncoSwab has offices in San Francisco, California and Corroux, Switzerland.

Data-driven patient recovery.

DoMore Diagnostics uses artificial intelligence to make personalized treatment decisions simple and accessible for all cancer patients. Its unique digital biomarkers predict patient outcomes from routine tumor tissue slides and can be seamlessly integrated into pathologists’ existing workflow. The lead product Histotype Px® Colorectal is a CE-IVDD marked outcome prediction marker for stage II and III colorectal adenocarcinoma that informs the decision of whether to provide adjuvant chemotherapy following surgical resection of the tumor. The company is based on prominent international research from leading universities and funded by top Norwegian tech investors.

Increase the success rates of In-vitro fertilization (IVF) treatments by an innovative medical device solution, combining hardware & AI-driven software.

The smart baby brand Kluba Medical is the solution based brand for parents and healthcare professional working with babies. Our Medibino brand gets parents with smart solutions that simplify parenting and care. With our new sustainable and fully biodegradable baby line we provide the first cradle-to-cradle baby textiles that are produced from 100% ecologically pure materials and substances. For us, sustainability is not a trend but an attitude, and responsibility towards our environment is not an option but a must. Our Kluba Medical brand provides solutions for the development-promoting care of (premature) babies in hospitals and connects patients, care givers and parents for the wellbeing of the smallest. About mothers, doctors and crooked heads What happens when two mothers, one doctor and one entrepreneur join forces? Products are created for the healthy development of babies. In the beginning we were concerned with healthy heads and developed the Medibino headguard: A patented medical device against plagiocephaly (flat head) in babies. The product was developed in Dr. Dr. Kluba‘s work as a doctor at the University Hospital of Tübingen, where she has been caring for affected children and their families for many years. We received medical device registration at the end of 2018 for the Medibino positioning. Solutions for the smallest of the small The market entry of Medibino has aroused desire in the clinical environment, as premature babies and newborns, who have to spend longer periods of time in the clinic, are particularly often affected by head deformities. We have seized this opportunity and, in close cooperation with leading perinatal centers in Germany, have developed a clinical head positioning system. Smart, fair, sustainable and healthy products Now we develop smart and sustainable solutions to simplify parenting in care in the following categories: • Healthy and safe sleep • Growing with security • Smart everyday helpers • Healthy textiles

Elastrin Therapeutics is a UK and US-based biotech developing novel therapies to reverse cardiovascular disease. Its underlying technology was developed by Dr. Naren Vyavahare during the last 20 years at Clemson University, in collaboration with Dr. Charles Rice. Our team built a proprietary platform that targets and restores degraded elastin by removing the harmful calcification that stiffens arteries.

At PL BioScience, we are experts in Human Platelet Lysate. Our mission is to support advances in cellular research and therapy with our revolutionary technology: the ELAREM™ HPL platform. Its xeno-free origin, combined with its naturally rich growth factor content not only supports cell growth and expansion, but also enables various applications. And with Research- and GMP-grade products available, ELAREM™ covers all steps of cell expansion in academic research, pre-clinical research and cellular therapy. This ensures seamless transitions in regenerative medicine – from blood bank, to bench, to bedside. Our story goes back to 2015, with the mission to deliver xeno-free cell culture supplements. Today, we continue to change the possibilities of cell expansion; researchers switch from Fetal Bovine Serum to our animal suffering-free products. Our signature innovation continues to guide us, as we work to support all stages of research, with premium quality HPL. Join us today in Innovating Cell Culture!

Carpe was founded with one mission: to help those suffering with embarrassing, uncomfortable sweat. We are reimagining everything that antiperspirants and sweat control can be. We grew up with sweaty palms, hesitating to hold a hand or reach for that handshake. We spent a year developing over 60 prototypes until we created a product that worked for us. After launching in 2014, we heard from countless customers for whom nothing else had worked asking us to expand our sweat solution line. We have grown into a full suite of products designed to help no matter where, no matter why, and no matter how much you sweat.

VISSEIRO is working every day to transform health care and offer the best quality of life to the elderly population. We enable tailored proactive health care. Because we care.

Pryon provides a trusted, safe, and proven path to implementing generative AI in enterprises. Pryons best-in-class ingestion and retrieval engines can be paired with generative LLMs to implement retrieval-augmented generation and securely provide accurate, instant, and verifiable answers at enterprise scale. Using industry-leading retrieval technology, Pryon RAG Suite securely extracts answers from all forms of content, including audio, images, text, and video, stored in a myriad of sources. Pryon’s products are intuitive to use, accessible via API from any system, and can be deployed in a matter of weeks in the cloud or on-premises. Created by the AI pioneers instrumental in developing Alexa, Siri, and Watson, Pryon is trusted by leading enterprises and government agencies. By reducing the distance between people and answers, Pryon builds high-performing, resilient, and responsive organizations. For more information, or to request a demo, visit https://pryon.com/.

Alveo Technologies is the first company to make molecular detection and diagnostics universally accessible – on the farm, in the field, in the clinic, or in the manufacturing plant – helping prevent or significantly limit the destructive impact of viruses, fungi, bacteria, and other pathogens by detecting earlier at the Point of Need™. Alveo’s portable, multiplex-capable diagnostic platform employs a patented method of direct electrical sensing of nucleic acid amplification to provide affordable, rapid, and accurate results. By enabling early pathogen detection, Alveo helps manage global health, food security, and supply chain resiliency by providing actionable insights at light speed. Know Sooner, Act Faster™ with Alveo. For more, visit: https://www.alveotechnologies.com/

FerroSens has developed proprietary technology that allows reliable non-invasive detection of iron deficiency. It is based on an optical measurement on the lower lip providing an immediate result at the point of care.

Adhesys Medical GmbH is a high-tech medical device startup with offices in Boston, MA and Aachen, Germany. Based on the patent-protected technology platform, the company develops high-strength biodegradable surgical adhesives that can be used on the skin and inside the body. Since April 2017, Adhesys Medical is a wholly-owned subsidiary of the German pharmaceutical company Grünenthal Group. Since January 2018, the first of Adhesys’ products (Flix®) has a European-wide CE certification..

Macula is transforming clinical microscopy workflow by deploying a compact and rapid computational imaging platform to enable true hands-off automation. Your whole slide is scanned and interpreted on-board leveraging latest AI/ML architectures in minutes. Report and high-fidelity images are available on the system for local or remote review.

Ginolis specializes in precision robotics in assembly automation, high precision liquid handling and quality inspection solutions for the global medical device and diagnostics industries as well as other robot applications. Ginolis aims to be one of the leading global systems suppliers in the diagnostics industry to enable the shift to automated production. The company’s liquid handling and desktop automation solutions are characterized by their high quality, precision and modularity. Ginolis is privileged to work in co-operation with many of the world’s leading diagnostic companies.

OMAPiX, Inc., a dynamic solutions-driven CRO based in Frederick, MD, delivers concierge multiomics services tailored to tackle a wide range of scientific challenges. Our technology-agnostic lab, combined with cutting-edge custom analysis methods, provides seamless end-to-end solutions across genomics, transcriptomics, and proteomics. Backed by extensive hands-on expertise in both wet lab and analytical techniques, OMAPiX is a trusted partner for academia, biotech, and pharma, supporting every stage of research with confidence and precision.

75% of lung cancer cases are detected too late. OncoSwab is changing that. Our mission: make early detection accessible with a non-invasive, easy-to-use test. Founded by visionary scientists and supported by the Health Wildcatters Accelerator, Swiss Governments DayOne Tech, and several pre-seed investors, OncoSwab is currently conducting a proof-of-concept trial with the collaboration of top US and European hospitals and lung cancer experts, aiming to save lives worldwide. OncoSwab has offices in San Francisco, California and Corroux, Switzerland.

Data-driven patient recovery.